确诊即晚期！演员朱媛媛因卵巢癌离世，这种疾病早期为何难发现

Core Insights - Approximately two-thirds of ovarian cancer patients are diagnosed at an advanced stage, with 82% of late-stage patients experiencing tumor recurrence [1][2] - Ovarian cancer is the leading cause of death among gynecological malignancies, despite having the lowest incidence rate among major gynecological cancers [1] - Early diagnosis and treatment are crucial, as the five-year survival rate varies significantly between early and late-stage diagnoses [1][2] Industry Statistics - Annually, around 61,000 women in China are diagnosed with ovarian cancer, leading to approximately 32,000 deaths from the disease [1] - Over 80% of women lack sufficient awareness of the risks associated with ovarian cancer, with only a small percentage understanding prevention and early warning signs [1] - The five-year survival rate for stage I ovarian cancer can reach 90%, while it drops to 30%-40% for stage III and below 10% for stage IV [1] Research and Treatment Insights - The deep pelvic location of the ovaries makes early tumors difficult to detect, often leading to misdiagnosis as gastrointestinal issues [2] - Genetic mutations, particularly in the BRCA gene, are associated with a higher risk of ovarian cancer, prompting recommendations for genetic testing in high-risk individuals [2] - Recent studies suggest that surgical treatment for recurrent ovarian cancer may yield better long-term outcomes compared to chemotherapy, with a reported 13% increase in long-term disease-free survival [2]